跳至主要内容
临床试验/NCT01726205
NCT01726205已完成4 期

Perioperative Pregabalin and Continuous Wound Infusion for Pain Control Following Thoracotomy

Attikon Hospital1 个研究点 分布在 1 个国家目标入组 45 人开始时间: 2008年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
45
试验地点
1
主要终点
Pain control

研究概览

简要总结

The purpose of this study is to assess the efficacy of pregabalin or pregabalin and continuous wound infusion versus placebo for analgesia following thoracotomy

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients scheduled for a thoracotomy,

排除标准

  • age >70 years
  • BMI > 30
  • preoperative Hb < 10 mg/dL
  • preexistent chronic pain
  • neurologic disease
  • chronic assumption of alcohol
  • treatment with analgesics, anxiolytics, sedatives, antidepressants, or calcium channel inhibitors

研究组 & 干预措施

pregabalin

Active Comparator

perioperative pregabalin starting the evening before surgery, and for five days postoperatively

干预措施: Pregabalin and normal saline infusion, PRG (Drug)

pregabalin and continuous wound infusion

Active Comparator

Pregabalin as previous group and continuous infusion of ropivacaine 0.2% via a wound catheter

干预措施: Pregabalin and ropivacaine 02% infusion (Drug)

placebo

Placebo Comparator

Placebo drug and normal saline infusion

干预措施: Placebo drug, normal saline infusion (Drug)

结局指标

主要结局

Pain control

时间窗: 5 days postoperatively

次要结局

  • morphine consumption(3 days postoperatively)

研究者

发起方
Attikon Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Sidiropoulou Tatiana

Lecturer in Anesthesiology, University of Athens

Attikon Hospital

研究点 (1)

Loading locations...

相似试验